pentadecanoic acid
AssetAlso C15:0, NSC-28486, FEMA NO. 4334
Essential odd-chain saturated fatty acid supplement supporting red blood cell membrane health and longevity
- Stage
- Phase 2
- Modality
- Supplement
- Target
- Mitochondrial biogenesis (PGC-1α)
- 2
- Indications
- 1
- Trial
- 1
- Developer
Indications
2Biological aging
Phase 2, Not yet recruiting, NCT07812792, clinicaltrials.gov, 7 Oct 2026
Red blood cell health
Phase 2, Not yet recruiting, NCT07812792, clinicaltrials.gov, 7 Oct 2026
In the full profile
- Targets and what it contains3
- Owner and partners1
- Trials1
- Evidence for its targets3
- Aging relevance2
- Signals3
Every asset’s record: target, stage, trials and the evidence behind it.